PAR-20-298: Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to understand the contribution of specific elements of maternal molecular and cellular factors that can control and effect the development of the fetal immune system.